According to CITIC Securities, Chinese traditional Chinese m...
According to CITIC Securities, Chinese traditional Chinese medicine has shown deep development potential and advantages, including long-standing brand influence, full industry chain layout, R&D strength, and new business exploration. The bank expects that with the promotion of national standards for traditional Chinese medicine formula granules and the expansion of medical institutions, performance is expected to resume rapid growth.
CITIC Securities: Target price of HK$4 for the initial “increase in holdings” rating for Chinese Traditional Chinese Medicine (00570)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment